Miguel Montero-Baker, MD, Gregory J

Slides:

Advertisements

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results M. Ferreira, L. Lanziotti, M. Monteiro, G.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease Andrew J. Meltzer, MD, Gautam.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Endovascular therapy for acute limb ischemia

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,

Stenting of femoropopliteal lesions using interwoven nitinol stents

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score Daniel M. Ihnat,

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease Hasan H. Dosluoglu, MD, Purandath Lall,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Danielle B. Cameron, BA, James H. Black, MD, Elliot K

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

The first operation on the profunda femoris artery

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Magdiel Trinidad-Hernandez, MD, Joseph J

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Remote endarterectomy: Lessons learned after more than 100 cases

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access Evan R. Brownie,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts Ahsan T. Ali, MD, J. Gregory Modrall,

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

Benign superior vena cava syndrome: Stenting is now the first line of treatment Adnan Z. Rizvi, MD, Manju Kalra, MBBS, Haraldur Bjarnason, MD, Thomas.

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

The Use of Micro-Oxygen Sensors (MOXYs) to Determine Dynamic Relative Oxygen Indices in the Foot of Patients with Critical Limb Ischemia (CLI) During.

Mortality in patients with premature lower extremity atherosclerosis

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Pedal bypass surgery after crural endovascular intervention

A telephone call 1 week after hospitalization can identify risk factors for vascular surgery readmission John R. Hornick, MD, Joshua A. Balderman, MD,

Peter Neglén, MD, PhD, Kathryn C. Hollis, BA, Seshadri Raju, MD

Primary stenting of the superficial femoral and popliteal artery

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Complications of iliac artery stent deployment

Endoscopic vein harvest for infrainguinal arterial bypass

Reconstructive surgery for complex aortoiliac occlusive disease in young adults Enzo Ballotta, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD, Francesca.

Endovascular repair of an acute blunt popliteal artery injury

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff Christopher J. Abularrage,

Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery Luis R. León, MD, RVT, Robert.

Endovascular treatment of celiac and mesenteric arteries stenoses: Applications and results Melhem J Sharafuddin, MD, Craig H Olson, BS, Shiliang Sun,

The use of dextran and carbon dioxide for optical coherence tomography in the superficial femoral artery Matthew T. Allemang, MD, Ryan O. Lakin, MD,

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England Ryan M. Svoboda, Karina A.

Femorofemoral bypass with femoral popliteal vein

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Endovascular interventions for TASC II D femoropopliteal lesions

Emily Spangler, Robert W. Chang, Philip P. Goodney

Endovascular brachytherapy for renal artery in-stent restenosis

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Analysis of endovascular therapy for femoropopliteal disease with the Supera stent Miguel Montero-Baker, MD, Gregory J. Ziomek, BS, Luis Leon, MD, Aaron Gonzales, BS, Robert S. Dieter, MD, Crystal L. Gadd, MD, John P. Pacanowski, MD Journal of Vascular Surgery Volume 64, Issue 4, Pages 1002-1008 (October 2016) DOI: 10.1016/j.jvs.2016.04.053 Copyright © 2016 Terms and Conditions

Fig 1 Primary patency of the superficial femoral artery (SFA). SE, Standard error. Journal of Vascular Surgery 2016 64, 1002-1008DOI: (10.1016/j.jvs.2016.04.053) Copyright © 2016 Terms and Conditions

Fig 2 Primary assisted patency of the superficial femoral artery (SFA). SE, Standard error. Journal of Vascular Surgery 2016 64, 1002-1008DOI: (10.1016/j.jvs.2016.04.053) Copyright © 2016 Terms and Conditions

Fig 3 Secondary patency. SE, Standard error. Journal of Vascular Surgery 2016 64, 1002-1008DOI: (10.1016/j.jvs.2016.04.053) Copyright © 2016 Terms and Conditions

Fig 4 Cox hazard ratio analysis. As seen in this image, a history of coronary artery disease (CAD) was found to be a protective factor against loss of patency. The other variables were associated with an increased risk of loss of patency. L, Long; M, medium. Journal of Vascular Surgery 2016 64, 1002-1008DOI: (10.1016/j.jvs.2016.04.053) Copyright © 2016 Terms and Conditions